Arteriosclerosis, Thrombosis, and Vascular Biology

Arteriosclerosis, Thrombosis, and Vascular Biology
DisciplineCardiology, cardiovascular biology
LanguageEnglish
Edited byAlan Daugherty
Publication details
Former name(s)
Arteriosclerosis; Arteriosclerosis and Thrombosis
History1981–present
Publisher
FrequencyMonthly
Hybrid
10.514 (2021)
Standard abbreviations
ISO 4Arterioscler. Thromb. Vasc. Biol.
Indexing
CODENATVBFA
ISSN1079-5642 (print)
1524-4636 (web)
LCCN95644718
OCLC no.31441121
Links

Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) is a peer-reviewed medical journal published on behalf of the American Heart Association by Lippincott Williams & Wilkins, an imprint of Wolters Kluwer. It covers basic and clinical research related to vascular biology, pathophysiology and complications of atherosclerosis, and thrombotic mechanisms in blood vessels.

The journal was established in 1981 as Arteriosclerosis (ISSN 0276-5047), which was published bimonthly. From 1991 to 1994 it was published monthly under the title Arteriosclerosis and Thrombosis: A Journal of Vascular Biology (ISSN 1049-8834).[1]

According to the Journal Citation Reports, the journal has a 2020 impact factor of 8.311,[2] ranking it 8th in the category "Hematology"[2] and 5th in the category "Peripheral Vascular Disease".[2] Alan Daugherty has been the editor-in-chief since 2012.[3]

  1. ^ National Library of Medicine online catalog. Accessed 2009-08-31.
  2. ^ a b c 2020 Journal Citation Reports. (Clarivate Analytics, 2021).
  3. ^ "About Arteriosclerosis, Thrombosis, and Vascular Biology". American Heart Association.